165 related articles for article (PubMed ID: 18516293)
1. Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas.
Gu P; Xing X; Tänzer M; Röcken C; Weichert W; Ivanauskas A; Pross M; Peitz U; Malfertheiner P; Schmid RM; Ebert MP
Neoplasia; 2008 Jun; 10(6):563-72. PubMed ID: 18516293
[TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis.
Darnton SJ; Hardie LJ; Muc RS; Wild CP; Casson AG
Int J Cancer; 2005 Jun; 115(3):351-8. PubMed ID: 15688381
[TBL] [Abstract][Full Text] [Related]
3. Methylated TIMP-3 DNA in body fluids is an independent prognostic factor for gastric cancer.
Yu JL; Lv P; Han J; Zhu X; Hong LL; Zhu WY; Wang XB; Wu YC; Li P; Ling ZQ
Arch Pathol Lab Med; 2014 Nov; 138(11):1466-73. PubMed ID: 25357107
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
5. Quantitative detection of TIMP-3 promoter hypermethylation and its prognostic significance in esophageal squamous cell carcinoma.
Ninomiya I; Kawakami K; Fushida S; Fujimura T; Funaki H; Takamura H; Kitagawa H; Nakagawara H; Tajima H; Kayahara M; Ohta T
Oncol Rep; 2008 Dec; 20(6):1489-95. PubMed ID: 19020732
[TBL] [Abstract][Full Text] [Related]
6. Association Between Tissue Inhibitor of Metalloproteinase-3 Gene Methylation and Gastric Cancer Risk: A Meta-Analysis.
Cao J; Li Z; Yang L; Liu C; Luan X
Genet Test Mol Biomarkers; 2016 Aug; 20(8):427-31. PubMed ID: 27314831
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by dna hypermethylation of the 5'-CpG island in human gastric cancer cell lines.
Kang SH; Choi HH; Kim SG; Jong HS; Kim NK; Kim SJ; Bang YJ
Int J Cancer; 2000 Jun; 86(5):632-5. PubMed ID: 10797283
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic subgroups of esophageal and gastric adenocarcinoma with differential GATA5 DNA methylation associated with clinical and lifestyle factors.
Wang X; Kang GH; Campan M; Weisenberger DJ; Long TI; Cozen W; Bernstein L; Wu AH; Siegmund KD; Shibata D; Laird PW
PLoS One; 2011; 6(10):e25985. PubMed ID: 22028801
[TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomach.
Park J; Schulz S; Haaf J; Kairys JC; Waldman SA
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):739-44. PubMed ID: 12163327
[TBL] [Abstract][Full Text] [Related]
10. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.
Altorki N; Schwartz GK; Blundell M; Davis BM; Kelsen DP; Albino AP
Cancer; 1993 Aug; 72(3):649-57. PubMed ID: 8334620
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction.
Bashash M; Shah A; Hislop G; Treml M; Bretherick K; Janoo-Gilani R; Leach S; Le N; Bajdik C; Brooks-Wilson A
PLoS One; 2013; 8(3):e59157. PubMed ID: 23527119
[TBL] [Abstract][Full Text] [Related]
13. Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas.
O'Neal RL; Nam KT; LaFleur BJ; Barlow B; Nozaki K; Lee HJ; Kim WH; Yang HK; Shi C; Maitra A; Montgomery E; Washington MK; El Rifai W; Drapkin RI; Goldenring JR
Hum Pathol; 2013 May; 44(5):734-42. PubMed ID: 23084584
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of the CHFR gene in digestive tract cancer.
Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
Anticancer Res; 2006; 26(3A):1791-5. PubMed ID: 16827108
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia.
Marsman WA; Birjmohun RS; van Rees BP; Caspers E; Johan G; Offerhaus A; Bosma PJ; Jan J; van Lanschot B
Clin Cancer Res; 2004 Dec; 10(24):8479-85. PubMed ID: 15623628
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma.
Yamamura N; Kishimoto T
Exp Mol Pathol; 2012 Aug; 93(1):35-9. PubMed ID: 22472323
[TBL] [Abstract][Full Text] [Related]
18. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas: a study using in-situ hybridization.
Beuzen F; Dubois S; Fléjou JF
Histopathology; 2000 Sep; 37(3):241-9. PubMed ID: 10971700
[TBL] [Abstract][Full Text] [Related]
20. Polymeric immunoglobulin receptor-negative tumors represent a more aggressive type of adenocarcinomas of distal esophagus and gastroesophageal junction.
Gologan A; Acquafondata M; Dhir R; Sepulveda AR
Arch Pathol Lab Med; 2008 Aug; 132(8):1295-301. PubMed ID: 18684029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
